Join Our Special Webinar to learn about castPCR™ technology
Block the normal—see the mutant; find them with castPCR™ technology
Sensitivity has long been a primary limitation in cancer research. For each cell carrying a mutation of interest, tumor samples can contain hundreds or even thousands of normal cells. At the same time, the mutant DNA may differ from the normal DNA by as little as a single base-pair. TaqMan® Mutation Detection Assays address this classic signal-to-noise problem using a novel real-time PCR method that combines allele-specific primers to target mutant sequences with blocker oligos that prevent amplification of normal DNA.
In this webinar, we will teach you the technology behind these assays, show you what mutations you can target with them, and explain how to set up experiments and controls for your own research studies. Most importantly, we will demonstrate what sort of results you can expect using research on formalin-fixed, paraffin-embedded (FFPE) and breast cancer samples.
Tuesday, September 25, 2012 at 10 a.m. PT
Presented by David N. Keys, PhD
Senior Manager for TaqMan® Assays R&D, Life Technologies